Lennard, L., Cartwright, C., Wade, R., Richards, S., Mitchell, C., Kinsey, S., . . . Vora, A. (2010). The thiopurine methyltransferase TPMT *1/*3A genotype is associated with a better treatment outcome in the UK ALL97 trial for childhood acute lymphoblastic leukaemia; TPMT heterozygosity is not associated with secondary cancers.
শিকাগো স্টাইল (17 তম সংস্করণ) উদ্ধৃতিLennard, L., C. Cartwright, R. Wade, S. Richards, C. Mitchell, S. Kinsey, T. Eden, J. Lilleyman, এবং A. Vora. The Thiopurine Methyltransferase TPMT *1/*3A Genotype Is Associated with a Better Treatment Outcome in the UK ALL97 Trial for Childhood Acute Lymphoblastic Leukaemia; TPMT Heterozygosity Is Not Associated with Secondary Cancers. 2010.
M.L.A (9 ম সংস্করণ) উদ্ধৃতিLennard, L., et al. The Thiopurine Methyltransferase TPMT *1/*3A Genotype Is Associated with a Better Treatment Outcome in the UK ALL97 Trial for Childhood Acute Lymphoblastic Leukaemia; TPMT Heterozygosity Is Not Associated with Secondary Cancers. 2010.